{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:23:26Z","timestamp":1792023806991,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.coi.2026.102739","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T01:18:37Z","timestamp":1771291117000},"page":"102739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["T cells in Sj\u00f6gren\u2019s disease: update on their role in salivary gland pathogenesis and treatment"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5682-6085","authenticated-orcid":false,"given":"Gwenny M","family":"Verstappen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pringle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelis SM","family":"van der Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans GM","family":"Kroese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrika","family":"Bootsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102739_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","article-title":"Genetics and epigenetics of primary Sjogren syndrome: implications for future therapies","volume":"19","author":"Thorlacius","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrrheum.2010.118","article-title":"Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome","volume":"6","author":"Voulgarelis","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib3","first-page":"2428","article-title":"The lacrimal gland in Sjogren's syndrome: can we unravel its mystery using ultrasound?","volume":"40","author":"Yang","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","article-title":"Epithelial-immune cell interplay in primary Sjogren syndrome salivary gland pathogenesis","volume":"17","author":"Verstappen","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41584-025-01218-9","article-title":"Antigen-driven T cell responses in rheumatic diseases: insights from T cell receptor repertoire studies","volume":"21","author":"Garrido-Mesa","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib6","first-page":"210","article-title":"T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjogren's syndrome","volume":"18","author":"Skopouli","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.40676","article-title":"Tissue-resident memory CD8+ T cells acting as mediators of salivary gland damage in a Murine model of Sjogren's syndrome","volume":"71","author":"Gao","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19397-w","article-title":"Cytotoxic CD8(+) T cells may be drivers of tissue destruction in Sjogren's syndrome","volume":"12","author":"Kaneko","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2026.102739_bib9","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jaci.2016.01.024","article-title":"Cytometry by time-of-flight immunophenotyping identifies a blood Sjogren's signature correlating with disease activity and glandular inflammation","volume":"137","author":"Mingueneau","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2026.102739_bib10","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1093\/rheumatology\/kez004","article-title":"T cells in primary Sjogren's syndrome: targets for early intervention","volume":"60","author":"Verstappen","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2026.102739_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4049\/jimmunol.1600208","article-title":"Enhanced expression of Bruton's tyrosine kinase in B cells drives systemic autoimmunity by disrupting T cell homeostasis","volume":"197","author":"Corneth","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2026.102739_bib12","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/art.40165","article-title":"Attenuation of follicular helper T cell-dependent B cell hyperactivity by abatacept treatment in primary Sjogren's syndrome","volume":"69","author":"Verstappen","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.681941","article-title":"The transcriptome of paired major and minor salivary gland tissue in patients with primary Sjogren's syndrome","volume":"12","author":"Verstappen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102739_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaz4371","article-title":"Salivary gland macrophages and tissue-resident CD8(+) T cells cooperate for homeostatic organ surveillance","volume":"5","author":"Stolp","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2026.102739_bib15","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/art.10577","article-title":"Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren's syndrome","volume":"46","author":"Ogawa","year":"2002","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/art.41558","article-title":"Interleukin-7\/Interferon axis drives T cell and salivary gland epithelial cell interactions in Sjogren's syndrome","volume":"73","author":"Riviere","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_sbref17","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54686-0","article-title":"Molecular and spatial analysis of tertiary lymphoid structures in Sjogren's syndrome","volume":"16","author":"Nayar","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102739_bib18","first-page":"42","article-title":"Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjogren's syndrome patients","volume":"37","author":"van Ginkel","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib19","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1016\/S2665-9913(25)00181-X","article-title":"Machine learning to classify the focus score and Sjogren's disease using digitalised salivary gland biopsies: a retrospective cohort study","volume":"7","author":"Duquesne","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_sbref20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/art.42772","volume":"76","author":"Pontarini","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_sbref21","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/ard-2023-224842","article-title":"Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjogren's disease","volume":"83","author":"Gupta","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102739_bib22","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ard.2025.07.021","article-title":"Transcriptomic profiling of Sjogren's disease salivary glands identifies signatures associated with both follicular and extrafollicular responses linked to rheumatoid factor and anti-La\/SSB seropositivity","volume":"84","author":"Pontarini","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102739_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-07008-3","article-title":"T follicular helper 1 cells in blood potentially mirror salivary gland-infiltrating T cells in Sjogren's disease","volume":"15","author":"Abe","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2026.102739_bib24","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/annrheumdis-2020-217646","article-title":"Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjogren's syndrome with ectopic germinal centres and MALT lymphoma","volume":"79","author":"Pontarini","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102739_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3899\/jrheum.160313","article-title":"B cell depletion therapy normalizes circulating follicular Th cells in primary Sjogren syndrome","volume":"44","author":"Verstappen","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_sbref26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado4856","article-title":"IFN-gamma-producing T(H)1 cells and dysfunctional regulatory T cells contribute to the pathogenesis of Sjogren's disease","volume":"16","author":"Wang","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2026.102739_bib27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.celrep.2015.09.082","article-title":"The salivary gland acts as a sink for tissue-resident memory CD8(+) T cells, facilitating protection from local Cytomegalovirus infection","volume":"13","author":"Thom","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2026.102739_sbref28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167490","article-title":"Single-cell profiling reveals pathogenic role and differentiation trajectory of granzyme K+CD8+ T cells in primary Sjogren's syndrome","volume":"8","author":"Xu","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2026.102739_sbref29","article-title":"GZMK(+)CD8(+) T cells target a specific acinar cell type in Sjogren's disease","author":"Pranzatelli","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102739_sbref30","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard-2023-225069","article-title":"CD8(+) tissue-resident memory T cells are expanded in primary Sjogren's disease and can be therapeutically targeted by CD103 blockade","volume":"83","author":"Mauro","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102739_bib31","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.celrep.2017.08.078","article-title":"Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites","volume":"20","author":"Kumar","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2026.102739_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102185","article-title":"T cell immunity to cytomegalovirus infection","volume":"77","author":"Zangger","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2026.102739_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.677707","article-title":"Intracellular and extracellular roles of Granzyme K","volume":"12","author":"Bouwman","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102739_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00420","article-title":"Lack of conventional acinar cells in parotid salivary gland of patient taking an anti-PD-L1 immune checkpoint inhibitor","volume":"10","author":"Pringle","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.coi.2026.102739_bib35","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1634\/theoncologist.2018-0823","article-title":"Sicca syndrome associated with immune checkpoint inhibitor therapy","volume":"24","author":"Warner","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.coi.2026.102739_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adl2967","article-title":"NK cells restrain cytotoxic CD8(+) T cells in the submandibular gland via PD-1-PD-L1","volume":"9","author":"Borys","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2026.102739_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.151955","article-title":"Long-term abatacept treatment for 48 weeks in patients with primary Sjogren's syndrome: the open-label extension phase of the ASAP-III trial","volume":"53","author":"de Wolff","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102739_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/annrheumdis-2020-218599","article-title":"Efficacy and safety of abatacept in active primary Sjogren's syndrome: results of a phase III, randomised, placebo-controlled trial","volume":"80","author":"Baer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102739_bib39","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/S2665-9913(19)30160-2","article-title":"Abatacept treatment for patients with early active primary Sjogren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)","volume":"2","author":"van Nimwegen","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib40","first-page":"2362","article-title":"Abatacept use for 24 weeks has a limited effect on salivary gland inflammation in Sjogren's disease patients","volume":"42","author":"Nakshbandi","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(24)01211-X","article-title":"Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjogren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study","volume":"404","author":"Fisher","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2026.102739_sbref42","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/s41591-024-03009-3","article-title":"CD40 ligand antagonist dazodalibep in Sjogren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial","volume":"30","author":"St Clair","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102739_bib43","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/1744666X.2019.1624527","article-title":"Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sjogren's syndrome","volume":"15","author":"van der Heijden","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.coi.2026.102739_bib44","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S2665-9913(20)30057-6","article-title":"Leflunomide-hydroxychloroquine combination therapy in patients with primary Sjogren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial","volume":"2","author":"van der Heijden","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2026.102739_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1566377","article-title":"Proteins linked to type II interferon response in Sjogren's disease: novel indicators for disease monitoring and predicting treatment response to leflunomide and hydroxychloroquine combination therapy","volume":"16","author":"Wong","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102739_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.41451","article-title":"Efficacy and safety of low-dose interleukin 2 for primary Sjogren syndrome: a randomized clinical trial","volume":"5","author":"He","year":"2022","journal-title":"JAMA Netw Open"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:34:00Z","timestamp":1784540040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526000166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":46,"alternative-id":["S0952791526000166"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102739","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cells in Sj\u00f6gren\u2019s disease: update on their role in salivary gland pathogenesis and treatment","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102739"}}